Bone Marrow Aspirate Concentrate (BMAC)

Bone marrow aspirate concentrate (BMAC) is an autologous regenerative therapy that utilizes bone marrow–derived cellular components to support tissue repair in select musculoskeletal and degenerative conditions.

At Alypos, BMAC is considered only when clinically appropriate and delivered with image guidance and individualized planning rather than protocol-based application.

Precise Technique

BMAC involves minimally invasive bone marrow aspiration and processing, followed by targeted delivery under image guidance. Real-time ultrasound or fluoroscopy is used when appropriate to optimize accuracy and safety,

Technique is individualized to patient anatomy and clinical objectives rather than applied though predetermined protocols.

Preparation Environment

Biologic materials are processed within a dedicated Class II medical airflow hood to maintain controlled preparation conditions and support cellular integrity prior to reinjection.

This preperation environment reflects a procedureal standard beyond what is typically found in routine office-based injection practices.

When BMAC May Be Considered

BMAC may be considered in select orthopedic or degenerative conditions where structural tissue compromise is present and conservative measures have failed. In cases where bone marrow-derived therapy is not ideal, alternative autologous cellular sources may occasionally be evaluated.

Alternative Cellular Sources

In certain clinical scenarios, alternative autologous cellular sources may be considered when bone marrow–derived therapy is not optimal or when additional biologic support is warranted.

Adipose-Derived Cellular Therapy

In selected cases, minimally invasive harvest and processing of adipose tissue may be utilized for specific musculoskeletal or soft-tissue applications following detailed clinical evaluation.

Risks and Limitations

As with any medical procedure, BMAC carries risks and limitations that are reviewed during consultation. Response varies among individuals, and no specific outcome can be guaranteed.

BMAC at Alypos is integrated within a broader musculoskeletal and regenerative framework. Decisions regarding its use reflect clinical judgment, experience, and patient-specific factors rather than trends or standardized protocols.